首页> 外文期刊>Endoscopy International Open >Endoscopic Submucosal Dissection for Early Gastric Cancer using the Clutch Cutter: a large single-center experience
【24h】

Endoscopic Submucosal Dissection for Early Gastric Cancer using the Clutch Cutter: a large single-center experience

机译:使用离合切开术治疗早期胃癌的内镜黏膜下剥离术:丰富的单中心经验

获取原文
           

摘要

Background and study aims: The Clutch Cutter (CC) was developed to reduce the risk of complications related to endoscopic submucosal dissection (ESD) using knives. The CC is able to grasp and coagulate and/or incise the targeted tissue using electrosurgical current, like a biopsy technique. The aim of this study was to evaluate the efficacy and safety of ESD using the CC (ESD-CC) for early gastric cancer (EGC). Patients and methods: From June 2007 to March 2014, 325 consecutive patients with a diagnosis of EGC were enrolled in this prospective study. They had all satisfied the Japanese gastric cancer treatment guidelines for ESD indication, namely confirmation by preliminary endoscopy, endoscopic ultrasound, and endoscopic biopsies. The CC was used for all steps of ESD (marking, circumferential marginal incision, submucosal dissection, and hemostatic treatment). The therapeutic efficacy and safety were assessed. Results: The en-bloc resection rate was 99.7?% (324/325) and the R0 resection rate was 95.3?% (310/325). The mean operating time was 97.2 minutes. Perforation during ESD-CC occurred in one case (0.3?%), which was managed with conservative medical treatment after endoscopic closure of the perforation. Post-ESD-CC bleeding occurred in 11 cases (3.4?%), which were successfully treated by endoscopic hemostatic treatment. The R0 resection rate was significantly low in tumors?>?20?mm (88.9?%), and in the exclusion indication group (73.7?%). Significant differences were seen in the mean operating time, depending upon tumor size, histologic type, location, and indication criteria. Conclusions: ESD-CC is a technically efficient, safe, and easy method for resecting EGC.
机译:背景和研究目的:离合器切割器(CC)的开发是为了减少使用刀进行内镜黏膜下剥离术(ESD)相关并发症的风险。 CC能够像活检技术一样使用电外科手术电流来抓握,凝结和/或切开目标组织。这项研究的目的是评估使用CC(ESD-CC)对早期胃癌(EGC)进行ESD的疗效和安全性。患者和方法:从2007年6月至2014年3月,本研究共纳入325例诊断为EGC的患者。他们都满足了日本胃癌ESD适应症治疗指南,即通过初步内窥镜检查,内窥镜超声检查和内窥镜活检证实。 CC用于ESD的所有步骤(标记,圆周边缘切口,粘膜下剥离和止血治疗)。评估疗效和安全性。结果:大块切除率为99.7%(324/325),R0切除率为95.3%(310/325)。平均操作时间为97.2分钟。 ESD-CC期间发生穿孔1例(0.3%),在内窥镜下封闭穿孔后通过保守治疗进行处理。 ESD-CC后出血发生11例(3.4%),经内镜止血治疗成功。 ≥20mm的肿瘤(88.9%)和排除适应症组(73.7%)的R0切除率均明显较低。根据肿瘤大小,组织学类型,位置和适应症标准,平均手术时间差异显着。结论:ESD-CC是切除EGC的技术上有效,安全且容易的方法。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号